Strategic
Verfora acquires Qpharma
SourcingClub was not involved in this transaction.
Verfora, the consumer healthcare provider of the Galenica Group, acquires 51% of Qpharma. The Polish family business distributes prescription medicines, OTC products and dietary supplements in Poland, the Czech Republic and Slovakia and is already a distribution partner of Verfora.
Deal-Radar editorial team · responsible: Nick Herbig
Source from the same day: eqs-news.com , 18 Nov 2026
Who was involved.
- Buyer
- Verfora
- Target
- Qpharma
- Seller
- Inhaberfamilie
- Type
- Strategic
- Sector
- Healthcare & Medtech
- Country
Poland
- Source dated
- 18/11/2026
- Source
- eqs-news.com
Deal-Radar no. 47-060 · publicly reported, no guarantee · SourcingClub was not involved in this transaction. Report an error · Sources and limits
We report publicly announced information and link the source; we accept no liability for its accuracy. No offer and no investment, legal or tax advice. The operators of linked pages are responsible for their content. We correct errors as soon as we learn of them.
Valuation in this industry.
5.9 to 10.0times EBITDA
- 5.9x to 7.6xRevenue under €5m
- 7.0x to 9.0x€5m to €50m
- 8.2x to 10.0xover €50m
Market range for Healthcare & Medical Technology, not the price of this deal. Data basis: DUB KMU-Multiples, Q3/2026; preparation: SourcingClub.
Multiples by size class for Healthcare & Medical Technology 53 deals in this industry on the radar
November 2026 on the Deal-Radar.
104 of 269 deals so far are of the type Strategic.
- Strategic104
- Add-on41
- Funding round40
- Carve-out29
- Buy-out16
- Insolvency12
- Minority stake11
- Secondary8
- Succession6
- Merger2
New deals every day. By email on Mondays.
All deals of the previous week in one email, with source and adviser.



